APA (7th ed.) Citation

Kusunose, K., Imai, T., Tanaka, A., Dohi, K., Shiina, K., Yamada, T., . . . Node, K. (2021). Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: A sub analysis of the CANDLE trial. Cardiovascular Diabetology, 20(1), 1. https://doi.org/10.1186/s12933-021-01380-w

Chicago Style (17th ed.) Citation

Kusunose, Kenya, et al. "Effects of Canagliflozin on NT-proBNP Stratified by Left Ventricular Diastolic Function in Patients with Type 2 Diabetes and Chronic Heart Failure: A Sub Analysis of the CANDLE Trial." Cardiovascular Diabetology 20, no. 1 (2021): 1. https://doi.org/10.1186/s12933-021-01380-w.

MLA (9th ed.) Citation

Kusunose, Kenya, et al. "Effects of Canagliflozin on NT-proBNP Stratified by Left Ventricular Diastolic Function in Patients with Type 2 Diabetes and Chronic Heart Failure: A Sub Analysis of the CANDLE Trial." Cardiovascular Diabetology, vol. 20, no. 1, 2021, p. 1, https://doi.org/10.1186/s12933-021-01380-w.